VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $48,000 | -22.6% | 3,000 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $62,000 | +44.2% | 3,000 | 0.0% | 0.01% | +50.0% |
Q3 2017 | $43,000 | -17.3% | 3,000 | 0.0% | 0.00% | -33.3% |
Q2 2017 | $52,000 | +57.6% | 3,000 | 0.0% | 0.01% | +50.0% |
Q1 2017 | $33,000 | -55.4% | 3,000 | 0.0% | 0.00% | -55.6% |
Q4 2016 | $74,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $74,000 | +23.3% | 3,000 | 0.0% | 0.01% | +12.5% |
Q2 2016 | $60,000 | -55.9% | 3,000 | +290.6% | 0.01% | -61.9% |
Q3 2015 | $136,000 | -22.3% | 768 | -2.7% | 0.02% | -16.0% |
Q2 2015 | $175,000 | -11.6% | 789 | -19.9% | 0.02% | -13.8% |
Q1 2015 | $198,000 | +16.5% | 985 | -17.4% | 0.03% | +11.5% |
Q4 2014 | $170,000 | -46.7% | 1,192 | -51.1% | 0.03% | -48.0% |
Q3 2014 | $319,000 | +18.6% | 2,439 | +6.5% | 0.05% | +28.2% |
Q2 2014 | $269,000 | +61.1% | 2,291 | +77.0% | 0.04% | +69.6% |
Q1 2014 | $167,000 | +15.2% | 1,294 | +19.4% | 0.02% | +4.5% |
Q4 2013 | $145,000 | +61.1% | 1,084 | +25.2% | 0.02% | +57.1% |
Q3 2013 | $90,000 | +20.0% | 866 | -0.7% | 0.01% | -63.2% |
Q2 2013 | $75,000 | +13.6% | 872 | -0.3% | 0.04% | +2.7% |
Q1 2013 | $66,000 | -16.5% | 875 | -9.8% | 0.04% | -40.3% |
Q2 2012 | $79,000 | +5.3% | 970 | +11.2% | 0.06% | 0.0% |
Q1 2012 | $75,000 | – | 872 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |